RseB Determines the Threshold of OMP Signal Required for σ E Activation. RseB modulates the σ E induction of active DegS variants, leading us to consider whether it might also modulate σ E induction when DegS is activated by OMPs. We compared σ E induction in wild-type (WT) and ΔrseB cells using a library of inducers, which consisted of periplasmic cytochrome b 562 fused
In Escherichia coli, the σ E transcription factor monitors and maintains outer membrane (OM) integrity by activating genes required for assembly of its two key components, outer membrane proteins (OMPs) and lipopolysaccharide (LPS) and by transcribing small RNAs to down-regulate excess unassembled OMPs. σ E activity is governed by the rate of degradation of its membrane-spanning anti-σ factor, RseA. Importantly, the DegS protease can initiate RseA cleavage only when activated by binding to unassembled OMPs. The prevalent paradigm has been that the σ E response is controlled by the amount of activated DegS. Here we demonstrate that inactivation of a second negative regulator, the periplasmic protein RseB, is also required for σ E induction in vivo. Moreover, OMPs, previously known only to activate DegS, also generate a signal to antagonize RseB inhibition. This signal may be lipid related, as RseB is structurally similar to proteins that bind lipids. We propose that the use of an AND gate enables σ E to sense and integrate multivariate signals from the envelope. extracytoplasmic stress | anti-sigma | PDZ domain T he outer membrane (OM) of Gram-negative bacteria is their first line of defense against harsh environments. Both key components of the OM, outer membrane proteins (OMPs) and lipopolysaccharide (LPS), have complex assembly and insertion pathways (1) (2) (3) (4) . In Escherichia coli, OM homeostasis is primarily maintained by a transcription factor, σ E , whose regulon includes machinery for assembly and insertion of OMPs into the OM, small RNAs that down-regulate OMP expression, and components controlling LPS synthesis and transport (5, 6) .
An elaborate regulatory apparatus monitors envelope status to control σ E activity. Under steady-state growth, σ E is predominantly bound to RseA, σ E 's inner membrane (IM)-spanning anti-σ factor ( Fig. 1A) (7) (8) (9) . Accumulation of unassembled OMPs in the periplasm activates DegS, a trimeric IM-anchored serine protease, to initiate RseA degradation. Free DegS lacks significant catalytic activity because the oxyanion hole of the active site is inappropriately positioned (Fig. 1A) (10) . However, binding of the YxF tripeptide at the C terminus of unassembled OMPs to the DegS PDZ domain stabilizes the active protease conformation, allowing it to cleave the periplasmic domain of RseA ( Fig. 1B) (11) (12) (13) , thereby activating the protease cascade that degrades RseA (14) (15) (16) (17) (18) . This "activation" signal is an excellent indicator of OMP assembly problems, as the OMP C termini are inaccessible in properly assembled OM-localized OMPs (19) . Once released from its inhibitory interactions with RseA, σ E binds RNA polymerase and activates transcription. Thus, the intracellular concentration of active σ E primarily reflects the rate of RseA degradation, enabling fine temporal control over σ E activity (16) .
σ E also has a second negative regulator, the periplasmic protein RseB, which binds to RseA (Fig. 1A) (8, 20) . There is conflicting data about the role of RseB. Strains lacking RseB display only twofold increase in σ E activity, suggesting that RseB plays a minor role in the response (8) , but in vitro, RseB completely inhibits RseA degradation by OMP-activated DegS (21) . Moreover in vivo, OMP peptides are sufficient for σ E induction, although were thought only to activate DegS, suggesting that antagonizing RseB inhibition was not critical to the response. Our work clarifies this issue. We show that σ E activity is controlled by an AND gate, requiring both DegS activation and RseB inactivation for robust response (Fig. 1B) . Consistent with this finding, RseB sets the sensitivity of the σ E response to OMP signal. Additionally, we find that OMPs, previously known only to activate DegS, also antagonize RseB by inducing another cellular signal. Because RseB is structurally similar to proteins that bind lipids (22, 23) , it suggests that this signal is lipid related. We propose that the σ E pathway employs DegS and RseB to sense and integrate multivariate signals from the envelope.
Results
Intertwined Roles of DegS and RseB in σ E Induction. A variant of DegS lacking its PDZ domain (DegSΔPDZ) cleaves RseA in an OMP-independent fashion in vitro, but cells harboring this truncated enzyme display only ∼1.5-fold induction of σ E in vivo ( Fig. 2A) (11, 12) , raising the possibility that DegS activation per se may not be sufficient for full σ E induction. The logical candidate for an additional regulator is RseB, which binds tightly to RseA and impedes DegS cleavage of RseA in vitro. Indeed, removal of RseB in a DegSΔPDZ strain led to synergistic σ E induction ( Fig. 2A) . Although ΔrseB and DegSΔPDZ single mutants each activated σ E only ∼1.5to 2-fold, the double mutant ΔrseB DegSΔPDZ strain showed ∼12-fold activation. Additionally, amino acid substitutions in DegS that decrease the free-energy gap between its active and inactive conformations and increase basal cleavage activity in vitro (12, 13, 24) are also synergistic with ΔrseB ( Fig. 2B ). K243D, which breaks the inhibitory interactions between the PDZ and protease domains of DegS, and H198P, which stabilizes the functional conformation of the oxyanion hole, each induces σ E only a few fold, but in combination with ΔrseB showed ∼15to 20-fold σ E induction. Thus, both DegS activation and RseB removal are required for robust activation of σ E . to the C-terminal 50 amino acids of OmpC (Cyt-OmpC 50 ) and variants in which the penultimate residue of the OmpC C terminus (YQF) was changed to correspond to each YxF motif identified in E. coli OMPs (11) .
We expressed each YxF fusion protein from the P trc promoter in the presence of 1 mM of IPTG and measured σ E activity. In WT cells, σ E activation correlated with binding affinity of the YxF motif for the PDZ domain of DegS ( Fig. 3A) , consistent with the fact that this parameter governs DegS activation in vitro (12) . In contrast, in ΔrseB cells, all YxF peptides displayed similar activation of σ E and were significantly better inducers than in the WT background ( Fig. 3B ). Therefore, we tested whether the absence of RseB lowered the threshold for OMP activation by assaying σ E induction from basal expression of fusion proteins (no IPTG; basal expression from the P trc promoter). Under these conditions, graded σ E activation was observed in ΔrseB cells, but no induction was observed in WT cells ( Fig. 3C ). These results are consistent with the idea that RseB modulates σ E activation by increasing the OMP peptide threshold.
We explored alternative explanations for the effect of RseB on σ E activation. We tested whether differential σ E activation in WT and ΔrseB cells resulted from differential expression of the fusion proteins using SDS/PAGE of periplasmic extracts to examine the proteins in the high-expression regime, and quantitative RT-PCR to examine transcription of fusion proteins in the lowexpression regime. Both studies showed that fusion proteins and their transcripts were present at equivalent levels in WT and ΔrseB cells, thus ruling out differential fusion protein expression as the cause of differential σ E activation ( Fig. S1 A and B) . Moreover, the increase in σ E activity in ΔrseB cells was not due to cleavage by another protease. Using a ΔrseBΔdegS strain expressing either WT DegS or catalytically inactive DegS (DegS-S201A), we demonstrate that active DegS is required for σ E induction upon expression of the YQF fusion ( Fig. 3D ). These findings together with data that ΔrseB cells expressing low con- centrations of YxF fusions exhibit σ E activation roughly proportional to the YxF affinities for DegS ( Fig. 3C ) strongly support a model in which RseB modulates the threshold for OMPpeptide activation of DegS.
Sequence Elements Upstream of the C-Terminal YxF Motif Affect RseB
Inhibition in Vivo. The three C-terminal residues of OMP peptides are sufficient for activating DegS in vitro; additional residues N-terminal to these generally inhibit and sometimes enhance activation (13) . We found that significantly more C-terminal OMP residues were necessary for induction in vivo. Using a Cterminal deletion series of fusion proteins containing 10, 20, 30, 40, and 50 C-terminal residues, we found that fusions ending with 20 (OmpC 20 ) or more OmpC residues activated σ E similarly, whereas the fusion ending with 10 OmpC residues (OmpC 10 ) displayed weak activity ( Fig. 4 A and B ). Because σ E induction in vivo involves both DegS activation and antagonizing RseB, we tested whether these additional OMP amino acids might be used for the latter process. Indeed, OmpC 10 activated σ E ∼75% as well as OmpC 20 in ΔrseB cells using basal-expression conditions to ensure that σ E activity is in the linear range ( Fig.  4C ). Increasing OmpC 10 affinity for DegS by changing its terminal tripeptide to YYF did not significantly activate WT cells but did show full activation in ΔrseB cells, indicating that a process other than DegS activation limits the ability of OmpC 10 to induce σ E in WT cells (compare Fig. 4 B and C) . These results demonstrate that an element located between 10 and 20 residues is required to antagonize RseB inhibition.
We asked whether upstream OMP sequences vary in their ability to counter RseB inhibition. Our test system compared σ E induction by "natural inducers" composed of the authentic 50 C-terminal residues of several OMPs with that of an OmpC 50 fusion protein having the same YxF motif as its "natural inducer" counterpart. Four natural inducers (OmpX, MipA, OmpG, and FadL) were better than their respective OmpC controls at inducing σ E (Fig. 5A) . Importantly, these same natural inducers performed the same as or worse than their OmpC counterparts in ΔrseB cells, where induction is dependent solely on DegS activation (Fig. 5B ). We conclude that OMPs vary in their ability to antagonize RseB inhibition, just as they vary in their ability to affect DegS activation.
We examined the DegS activation parameters of the OmpX 20 and OmpC 20 fusion proteins. As OmpX 20 activated WT cells twofold better than OmpC 20 , but was equivalent to OmpC 20 in activating in ΔrseB cells, their differential activation of σ E in vivo is attributed to differential antagonism of RseB ( Fig. 6 A and B) .
In an in vitro assay measuring DegS cleavage of the periplasmic domain of RseA, both OmpC 20 and OmpX 20 peptides supported roughly equal rates of DegS cleavage at peptide concentrations below 5 μM, with the OmpC 20 peptide showing higher activity at saturating concentrations (Fig. 6C ). These results are consistent with our hypothesis that the induction potential of OmpX 20 in vivo reflects stronger antagonism of RseB, as OmpX is not better than OmpC at activating DegS in vitro. Importantly, OmpX 20 did not antagonize RseB repression of RseA cleavage in vitro (Fig. 6D) . Therefore, relief of RseB inhibition is not mediated via direct binding by OmpX 20 to RseB, and likely requires additional regulatory components not present in our biochemical assays (see below and Discussion).
OMPs Generate Two σ E Induction Signals in Vivo. If OMP accumulation in vivo activates DegS and also induces a second signal that antagonizes RseB, then OMP accumulation might activate σ E in a DegS variant unable to bind OMP peptides (DegSΔPDZ). We previously found that overexpression of OmpC 50 did not alter DegSΔPDZ activity in vivo (11) . Here, we tested whether OmpX 50 , a strong antagonizer of RseB, activated σ E in a DegSΔPDZ strain. Indeed, in DegSΔPDZ, overexpression of OmpX 50 induced σ E activity twofold, whereas overexpression of OmpC 50 did not alter σ E activity (Fig. 7) . This result is consistent with the idea that some OMPs induce a second signal in vivo that antagonizes RseB inhibition.
Discussion
We have dissected the intertwined roles of DegS and RseB in control of the σ E response. Our results discriminate between two models for allosteric activation of DegS and show that DegS and RseB serve as joint gatekeepers for the response. Perturbing either gatekeeper leads to minor induction of the σ E response but joint perturbation leads to complete derepression. Two events are thus required for maximal σ E response, (i) OMP activation of DegS and (ii) relief of RseB inhibition by an envelope signal. We argue that the use of an AND gate enables the cell to simultaneously sense and integrate multivariate envelope signals.
Activation of DegS in Vivo. There are two competing models for the role of the PDZ domain in allosteric activation of DegS. In the "peptide-activation" model, the PDZ domain positions a bound OMP peptide, allowing its penultimate side chain to contact the protease domain and alter the conformation or dynamics of the active site to increase activity of DegS (10, 25) . Conversely, in the "inhibition-relief" model, the unliganded PDZ domain stabilizes the inactive conformation of the protease domain, and OMP-peptide binding relieves these inhibitory inter- actions (11) (12) (13) 24) . Our in vivo results provide two lines of evidence that support the inhibition-relief model. First, weakening the PDZ/protease interface increases rather than decreases DegS activity. K243D eliminates a salt bridge between the PDZ and protease domains (13) and has threefold higher basal σ E activity and four-to fivefold higher peptide-stimulated σ E activity compared with WT DegS (Fig. 2B and Fig. S2A ). Importantly, K243D does not increase activity in the context of DegSΔPDZ (Fig. S2B) , as expected if K243 exerts its effect solely by altering the PDZ/protease interface. Mutations such as H198P, which stabilize the active conformation of DegS (24, 26) , provide a second line of evidence that the PDZ domain is inhibitory. H198P increases σ E activity both in strains containing DegSΔPDZ, which does not bind OMP peptides, and WT DegS (Fig. 2B and Fig. S2 A and B) . In summary, our results indicate that the behavior of DegS in vivo is consistent with the predictions of the inhibition-relief model for allosteric activation of DegS.
Relief of RseB Inhibition Requires a Second Signal. The role of OMP peptides in activating DegS has been well characterized (12, 13, 24) . Here we show that OMP peptides also antagonize RseB inhibition. OMP amino acids between 10 and 20 residues from the C terminus are uniquely required for σ E induction in the presence of RseB (Fig. 4 ). OMP peptides differ in their ability to antagonize RseB ( Figs. 5 and 6 A and B) , just as they differ in their ability to activate DegS. Moreover, the OmpX peptide, identified as more proficient at RseB antagonism, can induce σ E even in a DegS variant that lacks the OMP docking domain (DegSΔPDZ), whereas the OmpC peptide, which is less proficient at RseB antagonism, cannot (Fig. 7) . Taken together, these results argue that OMP peptides play a dual role in inducing the σ E response, both activating DegS and relieving RseB inhibition.
How might OMPs generate a signal that antagonizes RseB in vivo? Our results argue strongly that they generate this signal indirectly, as OmpX is not able to antagonize RseB inhibition in an in vitro cleavage system (Fig. 6D ). Because RseB is structurally similar to the LolA, LolB, and LppX lipid-binding proteins (22, 23) , the RseB signal is most likely a lipophilic compound such as a periplasmic lipid, lipoprotein, or LPS. Intriguingly, there is a connection between OMP and LPS assembly. The β-barrel assembly machinery (BAM complex) is necessary to insert both OMPs and LptD, the critical player in LPS assembly, into the OM (27) (28) (29) (30) (31) . Accumulation of OMPs in the periplasm could therefore titrate the BAM machinery away from LptD. Decreased levels of LptD would reduce LPS insertion at the OM, resulting in its accumulation in the periplasm, which could signal the σ E pathway via RseB. This model is consistent with the previous data that changes in LPS structure induce σ E response (32, 33) . We are currently testing whether defects in LPS synthesis/transport activate σ E in an RseB-dependent manner.
Output Regime of the σ E Pathway. To provide an optimal response to inducing signals, signal-transduction pathways must sense signals over a wide concentration range, but at the same time discriminate between "stressed" and "unstressed" conditions. The E. coli σ E pathway achieves this distinction by using an AND gate to trigger the system. A robust response requires both activating DegS and antagonizing RseB inhibition. The synergistic nature of these two events is shown by differential σ E induction by activated DegS variants with and without RseB. When RseB is present, these variants show only minor σ E activation, but in the absence of RseB, each of these variants shows high σ E induction, consistent with their demonstrated ability to cleave RseA in an in vitro assay (Fig. 2) . This dual requirement for σ E induction is also evident in a physiological setting. Whereas high-level expression of a majority of YxF peptides failed to strongly activate σ E in WT cells, even weak peptides could achieve significant σ E induction in the absence of RseB ( Fig. 3 A and B) . Thus, removal of RseB magnifies the effects of OMP activation of DegS. RseB can be viewed as a "noise-filtering gatekeeper," which suppresses the contribution of noise in the signaling process and improves the information quality of the stress signal. This effect of RseB could be explained if RseB and active DegS (stabilized by OMP peptide) compete for binding to RseA. In WT cells, a larger number of active DegS molecules and therefore higher peptide amounts would be required for RseA cleavage compared with ΔrseB cells.
Use of an AND gate enables the cell to integrate multiple signals from the OM before committing to significant activation of σ E . Whereas the DegS gatekeeper responds to an unfolded OMP signal, RseB is likely to respond to a lipid signal. Because the σ E regulon encodes the machinery for assembly and insertion of both OM proteins and lipids, this signal integration would permit σ E to finely tune production of OM biogenesis machinery to the stresses at hand.
Materials and Methods
Media and Antibiotics. Luria-Bertani (LB) broth was prepared as described (34) . When required, LB was supplemented with 100 μg/mL of ampicillin (Ap) or 20 μg/mL of chloramphenicol (Cm). IPTG was added to induce the expression of cytochrome b 562 -OMP-protein fusions from P trc promoter.
Strains and Plasmids. Strains and plasmids used are listed in Table S1 , and details of their construction are available upon request. The ΔrseB strain carrying plasmids for strong σ E -activating OMP peptides and the ΔrseBΔdegS strain carrying plasmids for constitutively active DegS variants were unstable as glycerol stocks and lost σ E activity over time. Plasmids were freshly transformed to construct these strains.
β-Galactosidase Assays. σ E activity was measured by monitoring β-galactosidase (β-gal) expression from a chromosomal σ E -dependent lacZ reporter gene in Φλ(rpoHP3::lacZ), as described (35) (36) (37) . Cells were diluted from overnight cultures to OD 600 ∼0.01 in LB and grown at 30°C. For single point assays, the sample was harvested at an OD 600 listed in the figure legends, and σ E activity was calculated as Miller units. For differential plots, several samples were collected between 0.1 and 0.4 OD 600 , and β-gal activity/0.5 mL cells was plotted against OD 600 . The slope of these plots is the differential rate of β-gal synthesis and was used as the measure of σ E activity. All assays were performed at least twice and usually three times to ensure reproducibility. For β-gal assays involving OMP fusions, the proteins were overexpressed with 1 mM of IPTG in WT cells and with low induction in ΔrseB cells, enabling quantifiable σ E activity measurements within the linear range of each strain.
Biochemical Assays. DegS variants (residues with an N-terminal His 6 tag and RseA (residues 121-216) with a C-terminal His 6 tag were expressed and purified as described (12) . RseB (residues 24-318) with a C-terminal Leu-Glu-His 6 tag was expressed in E. coli strain X90(DE3) and purified by Ni ++ -NTA chromatography. The active dimeric fraction of RseB was separated from the inactive oligomeric fraction by gel-filtration chromatography and stored in 50 mM of NaHPO 4 (pH 8.0), 200 mM of NaCl, and 10% glycerol (21) . The OmpX 20 and OmpC 20 peptides were synthesized by the Massachusetts Institute of Technology Biopolymers Laboratory and purified by reversephase HPLC; their molecular weights were confirmed by MALDI-TOF mass spectrometry. DegS cleavage of 35 S-labeled RseA 121-216 was performed as described and quantified by scintillation counting of cleavage products soluble in cold trichloroacetic acid (12) .
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Chaba et al. 10 .1073/pnas.1019277108 SI Materials and Methods RNA Isolation, cDNA Preparation, and Quantitative RT-PCR. Cultures were grown in LB broth containing ampicillin at 30°C to ∼0.2 OD 600 . Samples (8 mL) were harvested and added to ice-cold 5% water-saturated acid phenol in ethanol solution, centrifuged at 6,600 × g for 2 min, and the cell pellets were flash frozen in liquid nitrogen before storing at −80°C until required. RNA was extracted using the hot-phenol technique, with modifications. Briefly, cell pellets were resuspended in 500 μL of lysis solution (40 mM of Na acetate, pH 4.6, 1% SDS, 20 mM of EDTA), and mixed with 1 mL of acid phenol. The samples were incubated at 65°C for 5 min with intermittent vortexing, placed on ice for 5 min, and centrifuged at 16,000 × g for 10 min at 4°C. The supernatant was extracted twice with phenol-chloroform, precipitated with 2.5 volumes of 100% ethanol, and washed with 70% ethanol. The RNA pellet was air dried and resuspended in 85 μL of RNase free water. Genomic DNA was then removed from the samples using Turbo DNA-free Turbo DNase Treat-ment according to the manufacturer's directions for rigorous DNase treatment (Applied Biosystems). cDNA was prepared for qRT-PCR as described (1), using 5 μg of input RNA using the Invitrogen SuperScriptIII First Strand cDNA Synthesis system.
Quantitative RT-PCR reactions were carried out using Stratagene Brilliant II SYBR green master mix according to the manufacturer's directions (Agilent Technologies), and 6 pmol of each forward and reverse primer (Integrated DNA Technologies). Real-time PCR was performed with a Stratagene Mx3000P sequence-detection system (Agilent Technologies). Data were analyzed as described (2) with recA and gyrA as references.
Preparation of Periplasmic Extracts. Cultures were grown in LB broth containing ampicillin and 5 μg/mL FeCl 2 at 30°C. Periplasmic extracts were prepared as described (3) . Samples were loaded on 15% polyacrylamide gels (19:1 acrylamide) and gels were stained with Coomassie Blue. Fig. S1 . Differential σ E activation in WT and ΔrseB cells does not result from differential protein expression in the two strain backgrounds. (A) Levels of YxF and lacZ transcripts under basal expression of YxF fusion proteins. WT and ΔrseB cells carrying plasmids for YQF or YYF fusion proteins were grown to OD 600 ∼0.2. Samples were harvested for RNA isolation, cDNA was prepared, and transcript abundance was assayed by qRT-PCR (SI Materials and Methods). Data were normalized to the transcript levels in WT cells expressing YQF-fusion protein and represent averages (±SD) of three independent experiments. (B) YQF-fusion protein levels upon high-level expression. WT and ΔrseB cells carrying plasmid for YQF fusion were grown to OD 600 ∼0.1. Cultures were induced with 1 mM of IPTG, grown to OD 600 ∼0.3, and harvested. Periplasmic extracts were prepared as described in SI Materials and Methods and samples were run on SDS/PAGE. FRT-flanked Kan R gene, pANTSγ, Kan R , Ap R (9) pKD46 oriR101 repA101ts P araBAD -λred, Ap R (9) 
